Acquired scalp alopecia. Part II: A review.
The neutrophil-associated and infiltrative scarring alopecias are reviewed including folliculitis decalvans, tufted folliculitis, dissecting cellulitis of the scalp, acne keloidalis and follicular degeneration syndrome. The management of acquired scalp alopecia is also reviewed including newer, promising therapies. More specific agents targeting components of the androgen system will make the treatment of androgenetic alopecia more rewarding. Similarly new immunomodulatory therapies show great promise for the lymphocyte-associated alopecias and include a new generation of macrolide immunosuppressives (tacrolimus, SDZ ASM 981, and SDZ 281-240), some of which appear to have good transcutaneous absorption.
Sullivan
J R
JR
Skin and Cancer Foundation, Sydney, New South Wales, Australia.
Kossard
S
S
D000505:Alopecia / Q000209:etiology* / Q000473:pathology / Q000628:therapy*; D000506:Alopecia Areata / Q000628:therapy; D005499:Folliculitis / Q000150:complications; D006801:Humans